Article History
Accepted: 23 August 2021
First Online: 15 September 2021
Declarations
:
: This manuscript received no funding.
: Mr. Trentino and Dr. Mace have nothing to disclose. Dr. Hofmann reports personal fees and non-financial support from Celgene, Belgium, personal fees and non-financial support from G1 Therapeutics, non-financial support from South African National Blood Service, South Africa, personal fees and non-financial support from Takeda, South Africa, personal fees and non-financial support from TEM Innovations, Germany, personal fees and non-financial support from Vifor Pharma International AG, Switzerland, and personal fees from Vygon SA, France, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.